MANKIND PHARMA   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
MANKIND PHARMA Last 5 Year EBIT Growth History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EBIT Growth(%) | 21.22 | 41.65 | -15.60 | 18.78 | 17.23 | 
What is the latest EBIT Growth ratio of MANKIND PHARMA ?
| Year | EBIT Growth | 
|---|---|
| Mar2025 | 21.22 | 
| Mar2024 | 41.65 | 
| Mar2023 | -15.60 | 
| Mar2022 | 18.78 | 
| Mar2021 | 17.23 | 
How is EBIT Growth of MANKIND PHARMA Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2025 | 21.22 | -49.05 | |
| Mar2024 | 41.65 | Positive | |
| Mar2023 | -15.6 | Negative | |
| Mar2022 | 18.78 | 9.00 | |
| Mar2021 | 17.23 | - | |
Other Financial Ratios of MANKIND PHARMA
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare EBIT Growth ratio of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹99,148.4 Cr | -0.1% | -1.5% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| MANKIND PHARMA |    -0.1%  | 
                            
                     
                     -1.5%  | 
                     
                     -5.7%  | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses